Results 241 to 250 of about 5,115,827 (299)

Complement Factor H-Based Therapeutics: A Comprehensive Overview. [PDF]

Eur J Immunol
Hamers SMWR, Buter EJ, Pouw RB.
europepmc   +1 more source

ZBTB11 Promotes Breast Cancer Progression by Activating FBXO28‐Mediated MST1 Degradation and Suppressing Hippo Signaling

Advanced Science, EarlyView.
ZBTB11 is identified as an oncogenic transcription factor that activates FBXO28 in breast cancer. FBXO28 promotes K48‐linked ubiquitination and degradation of MST1, suppressing Hippo signaling and enhancing epithelial–mesenchymal transition and metastasis. This transcription‐to‐ubiquitination cascade defines a prognostic biomarker axis and highlights a
An Xu, Xiang‐Nan Xu, Xiao Huang, Zhou Luo, Chun‐Lian Li, Yang Du, Cheng Yan, Xiao‐Jie Yu, Jian‐Wen Wang, Long‐Di Yao, De‐Yuan Fu   +10 more
wiley   +1 more source

Novel recombinant human adenoviruses: A call for enhanced molecular surveillance, diagnosis, and management in pediatric acute respiratory infections. [PDF]

Pediatr Investig
Zhu Z, Mao N.
europepmc   +1 more source

Cytochrome P450-Catalyzed Hydroxylation of Δ8-Tetrahydrocannabinol and Implications for Pharmacogenetics. [PDF]

Pharmaceutics
Zhao M, Lazarus P.
europepmc   +1 more source

Human Myeloid-Derived Growth Factor Induces a Pro-Angiogenic Response and Functional Recovery in a Mouse Model of Peripheral Artery Disease. [PDF]

Int J Mol Sci
Pekcec A, Myzithras M, Walther C, Ciossek T.   +3 more
europepmc   +1 more source

Adhesion-Enhanced Engineered Probiotic for Prolonged Intestinal Retention and Calprotectin-Responsive IBD Therapy. [PDF]

Adv Sci (Weinh)
Wang Y, Zhang P, Gu S, Lu H, Jiang N, Zhao J, Xu E, Liu X, Shi Y, Chen Q.   +9 more
europepmc   +1 more source

Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK. [PDF]

Signal Transduct Target Ther
Yang Y, Chen H, Xiang S, Wei Y, Zhang L, Sun A, E X, Wu F, Luo N, Liang F, Wu X, Wang C, Chen Z, Zhang Q, Chen X, Wu Q, Han Z, Li C, Yin R, Ren G, Li J, Zhao K, Gao H, Wang R, Yu M, Yang X.   +25 more
europepmc   +1 more source

Doing more with less in hemophilia B gene therapy. [PDF]

Blood Adv
Miesbach W.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recombinant protein expression for therapeutic applications

Current Opinion in Biotechnology, 2002
In recent years, the number of recombinant proteins used for therapeutic applications has increased dramatically. Many of these applications involve complex glycoproteins and antibodies with relatively high production needs. These demands have driven the development of a variety of improvements in protein expression technology, particularly involving ...
Dana C Andersen
exaly   +3 more sources